List of Tables
Table 1. Global Testosterone Injectable Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Testosterone Injectable Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Testosterone Injectable Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Testosterone Injectable Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Testosterone Injectable Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Testosterone Injectable Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Testosterone Injectable Sales by Region (2020-2025) & (K Units)
Table 8. Global Testosterone Injectable Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Testosterone Injectable Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Testosterone Injectable Sales Share by Manufacturers (2020-2025)
Table 12. Global Testosterone Injectable Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Testosterone Injectable Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Testosterone Injectable by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Injectable as of 2024)
Table 16. Global Testosterone Injectable Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Testosterone Injectable Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Testosterone Injectable Manufacturing Base and Headquarters
Table 19. Global Testosterone Injectable Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Testosterone Injectable Sales by Type (2020-2025) & (K Units)
Table 23. Global Testosterone Injectable Sales by Type (2026-2031) & (K Units)
Table 24. Global Testosterone Injectable Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Testosterone Injectable Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Testosterone Injectable ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Testosterone Injectable Sales by Application (2020-2025) & (K Units)
Table 29. Global Testosterone Injectable Sales by Application (2026-2031) & (K Units)
Table 30. Testosterone Injectable High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Testosterone Injectable Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Testosterone Injectable Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Testosterone Injectable ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Testosterone Injectable Growth Accelerators and Market Barriers
Table 37. North America Testosterone Injectable Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Testosterone Injectable Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Testosterone Injectable Growth Accelerators and Market Barriers
Table 40. Europe Testosterone Injectable Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Testosterone Injectable Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Testosterone Injectable Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Testosterone Injectable Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Testosterone Injectable Growth Accelerators and Market Barriers
Table 45. Southeast Asia Testosterone Injectable Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Testosterone Injectable Investment Opportunities and Key Challenges
Table 47. Central and South America Testosterone Injectable Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Testosterone Injectable Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Testosterone Injectable Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Clarus Therapeutics Corporation Information
Table 51. Clarus Therapeutics Description and Major Businesses
Table 52. Clarus Therapeutics Product Models, Descriptions and Specifications
Table 53. Clarus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Clarus Therapeutics Sales Value Proportion by Product in 2024
Table 55. Clarus Therapeutics Sales Value Proportion by Application in 2024
Table 56. Clarus Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 57. Clarus Therapeutics Testosterone Injectable SWOT Analysis
Table 58. Clarus Therapeutics Recent Developments
Table 59. Bayer Corporation Information
Table 60. Bayer Description and Major Businesses
Table 61. Bayer Product Models, Descriptions and Specifications
Table 62. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Bayer Sales Value Proportion by Product in 2024
Table 64. Bayer Sales Value Proportion by Application in 2024
Table 65. Bayer Sales Value Proportion by Geographic Area in 2024
Table 66. Bayer Testosterone Injectable SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Endo Pharmaceuticals Corporation Information
Table 69. Endo Pharmaceuticals Description and Major Businesses
Table 70. Endo Pharmaceuticals Product Models, Descriptions and Specifications
Table 71. Endo Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Endo Pharmaceuticals Sales Value Proportion by Product in 2024
Table 73. Endo Pharmaceuticals Sales Value Proportion by Application in 2024
Table 74. Endo Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 75. Endo Pharmaceuticals Testosterone Injectable SWOT Analysis
Table 76. Endo Pharmaceuticals Recent Developments
Table 77. Eli Lilly and Company Corporation Information
Table 78. Eli Lilly and Company Description and Major Businesses
Table 79. Eli Lilly and Company Product Models, Descriptions and Specifications
Table 80. Eli Lilly and Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Eli Lilly and Company Sales Value Proportion by Product in 2024
Table 82. Eli Lilly and Company Sales Value Proportion by Application in 2024
Table 83. Eli Lilly and Company Sales Value Proportion by Geographic Area in 2024
Table 84. Eli Lilly and Company Testosterone Injectable SWOT Analysis
Table 85. Eli Lilly and Company Recent Developments
Table 86. Kyowa Kirin International Corporation Information
Table 87. Kyowa Kirin International Description and Major Businesses
Table 88. Kyowa Kirin International Product Models, Descriptions and Specifications
Table 89. Kyowa Kirin International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Kyowa Kirin International Sales Value Proportion by Product in 2024
Table 91. Kyowa Kirin International Sales Value Proportion by Application in 2024
Table 92. Kyowa Kirin International Sales Value Proportion by Geographic Area in 2024
Table 93. Kyowa Kirin International Testosterone Injectable SWOT Analysis
Table 94. Kyowa Kirin International Recent Developments
Table 95. Viatris Corporation Information
Table 96. Viatris Description and Major Businesses
Table 97. Viatris Product Models, Descriptions and Specifications
Table 98. Viatris Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Viatris Recent Developments
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Major Businesses
Table 102. Novartis Product Models, Descriptions and Specifications
Table 103. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Novartis Recent Developments
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Product Models, Descriptions and Specifications
Table 108. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Pfizer Recent Developments
Table 110. J & K Scientific Corporation Information
Table 111. J & K Scientific Description and Major Businesses
Table 112. J & K Scientific Product Models, Descriptions and Specifications
Table 113. J & K Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. J & K Scientific Recent Developments
Table 115. Beijing Coupling Technology Corporation Information
Table 116. Beijing Coupling Technology Description and Major Businesses
Table 117. Beijing Coupling Technology Product Models, Descriptions and Specifications
Table 118. Beijing Coupling Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Beijing Coupling Technology Recent Developments
Table 120. Longyan Tianhua Biological Technology Corporation Information
Table 121. Longyan Tianhua Biological Technology Description and Major Businesses
Table 122. Longyan Tianhua Biological Technology Product Models, Descriptions and Specifications
Table 123. Longyan Tianhua Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Longyan Tianhua Biological Technology Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Testosterone Injectable Product Picture
Figure 2. Global Testosterone Injectable Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Testosterone Cypionate Product Picture
Figure 4. Testosterone Undecanoate Product Picture
Figure 5. Testosterone Enanthate Product Picture
Figure 6. Methyl testosterone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Testosterone Injectable Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospitals
Figure 10. Homecare
Figure 11. Specialty Clinics
Figure 12. Others
Figure 13. Testosterone Injectable Report Years Considered
Figure 14. Global Testosterone Injectable Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 16. Global Testosterone Injectable Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Testosterone Injectable Revenue Market Share by Region (2020-2031)
Figure 18. Global Testosterone Injectable Sales (2020-2031) & (K Units)
Figure 19. Global Testosterone Injectable Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Testosterone Injectable Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Testosterone Injectable Sales Volume Market Share in 2024
Figure 22. Global Testosterone Injectable Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Testosterone Cypionate Revenue Market Share by Manufacturer in 2024
Figure 25. Testosterone Undecanoate Revenue Market Share by Manufacturer in 2024
Figure 26. Testosterone Enanthate Revenue Market Share by Manufacturer in 2024
Figure 27. Methyl testosterone Revenue Market Share by Manufacturer in 2024
Figure 28. Others Revenue Market Share by Manufacturer in 2024
Figure 29. Global Testosterone Injectable Sales Market Share by Type (2020-2031)
Figure 30. Global Testosterone Injectable Revenue Market Share by Type (2020-2031)
Figure 31. Global Testosterone Injectable Sales Market Share by Application (2020-2031)
Figure 32. Global Testosterone Injectable Revenue Market Share by Application (2020-2031)
Figure 33. North America Testosterone Injectable Sales YoY (2020-2031) & (K Units)
Figure 34. North America Testosterone Injectable Revenue YoY (2020-2031) & (US$ Million)
Figure 35. North America Top 5 Manufacturers Testosterone Injectable Sales Revenue (US$ Million) in 2024
Figure 36. North America Testosterone Injectable Sales Volume (K Units) by Type (2020- 2031)
Figure 37. North America Testosterone Injectable Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 38. North America Testosterone Injectable Sales Volume (K Units) by Application (2020-2031)
Figure 39. North America Testosterone Injectable Sales Revenue (US$ Million) by Application (2020-2031)
Figure 40. US Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 41. Canada Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 42. Mexico Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 43. Europe Testosterone Injectable Sales YoY (2020-2031) & (K Units)
Figure 44. Europe Testosterone Injectable Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Europe Top 5 Manufacturers Testosterone Injectable Sales Revenue (US$ Million) in 2024
Figure 46. Europe Testosterone Injectable Sales Volume (K Units) by Type (2020-2031)
Figure 47. Europe Testosterone Injectable Sales Revenue (US$ Million) by Type (2020-2031)
Figure 48. Europe Testosterone Injectable Sales Volume (K Units) by Application (2020-2031)
Figure 49. Europe Testosterone Injectable Sales Revenue (US$ Million) by Application (2020-2031)
Figure 50. Germany Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 51. France Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 52. U.K. Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 53. Italy Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 54. Russia Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Testosterone Injectable Sales YoY (2020-2031) & (K Units)
Figure 56. Asia-Pacific Testosterone Injectable Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Top 8 Manufacturers Testosterone Injectable Sales Revenue (US$ Million) in 2024
Figure 58. Asia-Pacific Testosterone Injectable Sales Volume (K Units) by Type (2020- 2031)
Figure 59. Asia-Pacific Testosterone Injectable Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 60. Asia-Pacific Testosterone Injectable Sales Volume (K Units) by Application (2020-2031)
Figure 61. Asia-Pacific Testosterone Injectable Sales Revenue (US$ Million) by Application (2020-2031)
Figure 62. Indonesia Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 63. Japan Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 64. South Korea Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 65. China Taiwan Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 66. India Testosterone Injectable Revenue (2020-2031) & (US$ Million)
Figure 67. Central and South America Testosterone Injectable Sales YoY (2020-2031) & (K Units)
Figure 68. Central and South America Testosterone Injectable Revenue YoY (2020-2031) & (US$ Million)
Figure 69. Central and South America Top 5 Manufacturers Testosterone Injectable Sales Revenue (US$ Million) in 2024
Figure 70. Central and South America Testosterone Injectable Sales Volume (K Units) by Type (2021-2031)
Figure 71. Central and South America Testosterone Injectable Sales Revenue (US$ Million) by Type (2020-2031)
Figure 72. Central and South America Testosterone Injectable Sales Volume (K Units) by Application (2020-2031)
Figure 73. Central and South America Testosterone Injectable Sales Revenue (US$ Million) by Application (2020-2031)
Figure 74. Brazil Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 75. Argentina Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 76. Middle East, and Africa Testosterone Injectable Sales YoY (2020-2031) & (K Units)
Figure 77. Middle East and Africa Testosterone Injectable Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Middle East and Africa Top 5 Manufacturers Testosterone Injectable Sales Revenue (US$ Million) in 2024
Figure 79. Middle East and Africa Testosterone Injectable Sales Volume (K Units) by Type (2021-2031)
Figure 80. South America Testosterone Injectable Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Middle East and Africa Testosterone Injectable Sales Volume (K Units) by Application (2020-2031)
Figure 82. Middle East and Africa Testosterone Injectable Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. GCC Countries Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 84. Turkey Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 85. Egypt Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 86. South Africa Testosterone Injectable Revenue (2020-2025) & (US$ Million)
Figure 87. Testosterone Injectable Industry Chain Mapping
Figure 88. Regional Testosterone Injectable Manufacturing Base Distribution (%)
Figure 89. Global Testosterone Injectable Production Market Share by Region (2020-2031)
Figure 90. Testosterone Injectable Production Process
Figure 91. Regional Testosterone Injectable Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
